Advanced Biomed (ADVB) Income towards Parent Company (2023 - 2026)

Advanced Biomed has reported Income towards Parent Company for 3 years, with the latest figure at -$144257.0 in Q4 2025.

• Quarterly Income towards Parent Company rose 56.07% year-over-year to -$144257.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$2.0 million (down 27.57% YoY) and the FY2025 annual result came in at -$3.3 million, down 17.13% from the prior year.
• Income towards Parent Company advanced to -$144257.0 in Q4 2025 per ADVB's latest filing, from -$386901.0 in the prior quarter.
• Over five years, Income towards Parent Company peaked at -$144257.0 in Q4 2025 and troughed at -$1.5 million in Q2 2025.
• A 3-year average of -$535483.1 and a median of -$328410.0 in 2024 frame the typical range for Income towards Parent Company.
• The sharpest annual moves came in 2024 and 2025: Income towards Parent Company tumbled 125.95% in 2024, then soared 82.35% in 2025.
• Over 3 years, Income towards Parent Company stood at -$145345.0 in 2023, then sank by 125.95% to -$328410.0 in 2024, then soared by 56.07% to -$144257.0 in 2025.
• According to Business Quant data, Income towards Parent Company over the past three periods registered -$144257.0, -$386901.0, and -$1.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.